ACHV Achieve Life Sciences, Inc. - Common Shares
NASDAQ · Biotechnology · View on SEC EDGAR ↗ close Oct 2, 2026 10-K/10-Q Aug 11, 2026
$7.24
· of 52w range
· above low
· to high
$2.6252w low
$8.6452w high
Market Cap (MRQ)
$744M
P/E
-4.0
EPS
$-1.25
your badges
52W Range
$3–$9
Analyst Rating
BUY
Price Target
$14
P/E
-4.0
ROE
·
Net Profit Margin
·
Your badge strip is empty — pin a metric anywhere on this page.
ACHV Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range
Price
$7.24
Market Cap (MRQ)
$744M
P/E
-4.0
EPS
$-1.25
52W Range
$3–$9
ACHV Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view
range
bars
Bar granularity adapts to the selected period — hover the chart to see open/high/low/close for a bar.
Stock splits
| Ex-date | Split | Type |
|---|---|---|
| July 31, 2020 | 1-for-20 | Reverse |
| May 24, 2018 | 1-for-10 | Reverse |
| Aug. 3, 2017 | 1-for-11 | Reverse |
| Aug. 21, 2008 | 1-for-18 | Reverse |
10-Year Performance Revenue, net income, margins and EPS trends
Revenue·2018-12-31 → 2019-12-31
EPS$-1.252020-12-31 → 2025-12-31
Free Cash Flow·2016-12-31 → 2023-12-31
Valuation & Ratios
Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?
| Metric | 5Y trend | ACHV | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| P/E | -4.05Y avg ≈-2.4 | ≈-2.4 | · | · | |
| P/B (MRQ) | -50.75Y avg ≈-17.3 | ≈-17.3 | · | · | |
| Price / Tangible Book (MRQ) | -48.65Y avg ≈7.6 | ≈7.6 | · | · |
Peer median is calculated on a standardized basis per metric and may not always match the TTM/MRQ basis shown for this stock.
Profitability Gross, operating and net margins; ROE, ROA, ROIC
No data for this ratio group yet
Not enough fundamentals data to compute this ratio group yet.
Financial Health Debt, liquidity, solvency — balance sheet strength
| Metric | 5Y trend | ACHV | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Current Ratio (MRQ) | 1.05Y avg ≈5.4 | ≈5.4 | 8.0 | Low liquidity |
Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR
No data for this ratio group yet
Not enough fundamentals data to compute this ratio group yet.
Capital Efficiency Asset turnover, inventory turnover, receivables turnover
No data for this ratio group yet
Not enough fundamentals data to compute this ratio group yet.
value · ≈ 5Y avg · industry median · verdict relative to median
Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date
Avg Surprise
-54.8%
Next Report
Nov 04, 2026
| Period | Report | EPS Actual | EPS Est | Surprise |
|---|---|---|---|---|
| June 30, 2026 | Aug 6, 2026 | $-0.80 | $-0.16 | -405.7% |
| March 31, 2026 | May 11, 2026 | $-0.19 | $-0.31 | 39.6% |
| Dec. 31, 2025 | $-0.28 | $-0.28 | -1.1% | |
| Sept. 30, 2025 | $-0.28 | $-0.26 | -6.7% | |
| June 30, 2025 | $-0.37 | $-0.37 | 0.35% | |
| March 31, 2025 | $-0.37 | $-0.37 | 0.16% | |
| Dec. 31, 2024 | $-0.36 | $-0.33 | -10.3% |
Full Fundamentals All metrics by year — income statement, balance sheet, cash flow
Income Statement
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | · | · | · | · | · | · | $0 | $0 | |
| R&D Expense | · | $23M | $16M | $30M | $24M | $7M | $10M | $6M | |
| SG&A Expense | · | $16M | $11M | $11M | $9M | $8M | $7M | $7M | |
| Operating Expenses | $55M | $39M | $27M | $41M | $33M | $15M | $17M | $13M | |
| Interest Expense | · | · | $3M | $2M | · | · | · | · | |
| Interest Income | $1M | $2M | $825.0K | $199.0K | $17.0K | $69.0K | $170.0K | $171.0K | |
| Other Non-op | $-36.0K | $-30.0K | $-9.0K | $40.0K | $-75.0K | $-49.0K | $-37.0K | $-45.0K | |
| Pretax Income | $-55M | $-40M | $-30M | $-42M | $-33M | $-15M | $-16M | $-13M | |
| Net Income | $-55M | $-40M | $-30M | $-42M | $-33M | $-15M | $-16M | $-13M | |
| EPS (Basic) | $-1.25 | $-1.24 | $-1.50 | $-4.00 | $-4.08 | $-5.42 | · | · | |
| EPS (Diluted) | $-1.25 | $-1.24 | $-1.50 | $-4.00 | $-4.08 | $-5.42 | · | · | |
| Shares (Basic) | 43,594,652 | 32,071,146 | 19,827,534 | 10,593,034 | 8,119,836 | 2,718,909 | · | · | |
| Shares (Diluted) | 43,594,652 | 32,071,146 | 19,827,534 | 10,593,034 | 8,119,836 | 2,718,909 | · | · |
Balance Sheet
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $21M | $13M | $16M | $25M | $43M | $36M | $17M | $10M | |
| Short-term Investments | $15M | $22M | · | · | · | · | · | $5M | |
| Receivables | · | · | · | · | · | · | $8.0K | $7.0K | |
| Prepaid Expense | · | $2M | $1M | $2M | $1M | $1M | $670.0K | $926.0K | |
| Current Assets | $40M | $36M | $17M | $27M | $45M | $37M | $17M | $16M | |
| PP&E (Net) | $3.0K | $8.0K | $13.0K | $4.0K | $15.0K | $42.0K | $57.0K | $35.0K | |
| PP&E (Gross) | $256.0K | $256.0K | $256.0K | $303.0K | $302.0K | $674.0K | $657.0K | $755.0K | |
| Accum. Depreciation | $253.0K | $248.0K | $243.0K | $299.0K | $287.0K | $632.0K | $600.0K | $720.0K | |
| Goodwill | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | |
| Intangibles | $751.0K | $974.0K | $1M | $1M | $2M | $2M | $2M | $2M | |
| Other Non-current Assets | · | · | · | · | · | $187.0K | $187.0K | $118.0K | |
| Total Assets | $42M | $39M | $19M | $30M | $48M | $40M | $21M | $19M | |
| Accounts Payable | · | $2M | $618.0K | $2M | $841.0K | $332.0K | $859.0K | $144.0K | |
| Current Liabilities | $9M | $7M | $21M | $22M | $5M | $3M | $3M | $3M | |
| Capital Leases | $5.0K | $66.0K | $6.0K | $69.0K | $4.0K | $77.0K | $159.0K | $12.0K | |
| Total Liabilities | $20M | $18M | $21M | $22M | $19M | $3M | $3M | $3M | |
| Common Stock | $121.0K | $103.0K | $90.0K | $87.0K | $79.0K | $76.0K | $41.0K | $18.0K | |
| Retained Earnings | $-260M | $-206M | $-166M | $-136M | $-94M | $-60M | $-46M | $-25M | |
| AOCI | $10.0K | $31.0K | $4.0K | $4.0K | $4.0K | $4.0K | $4.0K | $4.0K | |
| Stockholders' Equity | $22M | $21M | $-1M | $8M | $28M | $37M | $18M | $16M | |
| Liabilities + Equity | $42M | $39M | $19M | $30M | $48M | $40M | $21M | $19M | |
| Shares Outstanding | 53,233,988 | 34,685,072 | 21,165,760 | 17,897,029 | 9,453,542 | 6,111,735 | 1,474,258 | 6,721,117 |
Cash Flow
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| D&A | $228.0K | $229.0K | $228.0K | $236.0K | $250.0K | $255.0K | · | · | |
| Stock-based Comp | $9M | $5M | $3M | $3M | $2M | $1M | $1M | $854.0K | |
| Amort. of Intangibles | $200.0K | $200.0K | $200.0K | $200.0K | $200.0K | $200.0K | $200.0K | $200.0K | |
| Operating Cash Flow | $-49M | $-30M | $-24M | $-38M | $-29M | $-13M | $-15M | $-11M | |
| CapEx | $3.0K | · | $21.0K | · | · | $17.0K | $53.0K | $46.0K | |
| Investing Cash Flow | $6M | $-22M | $-21.0K | · | · | $-17.0K | $5M | $-5M | |
| Financing Cash Flow | $52M | $49M | $15M | $19M | $37M | $33M | $17M | $20M | |
| Net Change in Cash | $8M | $-3M | $-9M | $-18M | $7M | $19M | $7M | $4M | |
| Taxes Paid | $0 | $0 | $0 | · | · | · | · | · | |
| Free Cash Flow | · | · | $-24M | · | · | $-13M | $-15M | $-11M |
Profitability
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| ROA | · | -137.3% | -120.8% | · | -75.5% | -48.0% | -81.6% | -87.6% | |
| ROE | · | -152.4% | -2302.3% | · | -105.7% | -46.8% | -125.2% | -84.7% |
Liquidity & Solvency
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | · | 5.5 | 0.8 | · | 9.8 | 12.6 | 6.0 | 4.8 | |
| Quick Ratio | · | 5.1 | 0.7 | · | 9.5 | 12.2 | 5.8 | 4.5 |
Efficiency
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | · | · | · | · | · | 0.0 | 0.0 | |
| Receivables Turnover | · | · | · | · | · | · | 0.0 | 0.0 |
Per Share
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | · | $0.60 | $-0.07 | · | $2.97 | $6.10 | $0.61 | $2.35 | |
| Cash Flow / Share | · | $-0.93 | $-1.23 | · | · | · | · | · | |
| Cash / Share | · | $0.37 | $0.73 | · | $4.55 | $5.87 | $0.57 | $1.42 | |
| EPS (TTM) | $-1.25 | $-1.24 | $-1.50 | $-4.00 | $-4.08 | $-5.42 | · | · |
Valuation (TTM)
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | · | · | · | · | · | · | $0 | $0 | |
| Net Income TTM | $-55M | $-40M | $-30M | $-42M | $-33M | $-15M | $-16M | $-13M | |
| Market Cap | · | $122M | $87M | · | $74M | $50M | $313M | $163M | |
| P/E | -4.0 | -2.8 | -2.7 | -0.6 | -1.9 | -1.5 | · | · | |
| P/B | · | 5.8 | -60.2 | · | 2.6 | 1.3 | 17.3 | 10.3 | |
| P / Tangible Book | 13.4 | 6.5 | · | 7.5 | 2.9 | 1.4 | · | · | |
| P / Cash Flow | · | -4.1 | -3.6 | · | -2.5 | -3.7 | -20.5 | -15.3 | |
| P / FCF | · | · | -3.6 | · | · | -3.7 | -20.5 | -15.2 | |
| Earnings Yield | -25.1% | -35.2% | -36.4% | -163.3% | -52.4% | -66.9% | · | · |
Income Statement
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expense | · | · | · | $5M | $7M | $7M | · | $8M | $5M | $3M | $4M | $5M | $6M | $10M | $7M | $4M | |
| SG&A Expense | · | · | · | $9M | $6M | $6M | · | $5M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | |
| Operating Expenses | $18M | $10M | $15M | $15M | $13M | $13M | $12M | $12M | $8M | $6M | $7M | $8M | $9M | $13M | $10M | $7M | |
| Interest Expense | · | · | · | · | · | · | · | $366.0K | $804.0K | $813.0K | $781.0K | $712.0K | $573.0K | $481.0K | $404.0K | $357.0K | |
| Interest Income | $1M | $297.0K | $427.0K | $554.0K | $192.0K | $322.0K | $482.0K | $673.0K | $833.0K | $368.0K | $262.0K | $193.0K | $162.0K | $73.0K | $4.0K | $4.0K | |
| Other Non-op | $-5.0K | $-13.0K | $7.0K | $-5.0K | $-59.0K | $21.0K | $-5.0K | $-8.0K | $-2.0K | $-15.0K | $-17.0K | $-6.0K | $-3.0K | $-30.0K | $5.0K | $6.0K | |
| Net Income | $-75M | $-10M | $-15M | $-14M | $-13M | $-13M | $-12M | $-13M | $-8M | $-6M | $-7M | $-8M | $-9M | $-13M | $-10M | $-8M | |
| EPS (Basic) | $-0.80 | $-0.19 | $-0.23 | $-0.28 | $-0.37 | $-0.37 | $-0.37 | $-0.36 | $-0.25 | $-0.26 | $-0.34 | $-0.43 | $-0.50 | $-1.35 | $-1.08 | $-0.80 | |
| EPS (Diluted) | $-0.80 | $-0.19 | $-0.23 | $-0.28 | $-0.37 | $-0.37 | $-0.37 | $-0.36 | $-0.25 | $-0.26 | $-0.34 | $-0.43 | $-0.50 | $-1.35 | $-1.08 | $-0.80 | |
| Shares (Basic) | 93,510,544 | 53,381,989 | · | 51,017,662 | 34,685,072 | 34,685,072 | · | 34,355,050 | 34,318,709 | 25,048,134 | 21,127,281 | 19,048,627 | 17,917,769 | 9,693,788 | 9,647,726 | 9,458,745 | |
| Shares (Diluted) | 93,510,544 | 53,381,989 | · | 51,017,662 | 34,685,072 | 34,685,072 | · | 34,355,050 | 34,318,709 | 25,048,134 | 21,127,281 | 19,048,627 | 17,917,769 | 9,693,788 | 9,647,726 | 9,458,745 |
Balance Sheet
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $48M | $28M | $21M | $32M | $52M | $13M | $13M | $10M | $15M | $66M | $20M | $25M | $17M | $18M | $29M | $36M | |
| Short-term Investments | $139M | $1M | $15M | $16M | $4M | $10M | $22M | $33M | $47M | · | · | · | · | · | · | · | |
| Prepaid Expense | · | · | · | $2M | $2M | $2M | · | $3M | $1M | $1M | $2M | $958.0K | $2M | $3M | $1M | $1M | |
| Current Assets | $188M | $31M | $40M | $50M | $57M | $25M | $36M | $46M | $63M | $68M | $22M | $26M | $18M | $21M | $31M | $38M | |
| PP&E (Net) | · | · | $3.0K | · | · | · | $8.0K | · | · | · | · | · | · | · | · | · | |
| PP&E (Gross) | · | · | $256.0K | · | · | · | $256.0K | · | · | · | · | · | · | · | · | · | |
| Accum. Depreciation | · | · | $253.0K | · | · | · | $248.0K | · | · | · | · | · | · | · | · | · | |
| Goodwill | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | |
| Intangibles | $640.0K | $696.0K | $751.0K | $807.0K | $863.0K | $918.0K | $974.0K | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $2M | $2M | |
| Total Assets | $190M | $33M | $42M | $52M | $59M | $27M | $39M | $48M | $65M | $70M | $24M | $29M | $21M | $24M | $34M | $41M | |
| Accounts Payable | · | · | · | $2M | $1M | $2M | · | $1M | $550.0K | $373.0K | $638.0K | $361.0K | $1M | $412.0K | $656.0K | $418.0K | |
| Accrued Liabilities | $200.0K | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Current Liabilities | $198M | $12M | $9M | $10M | $9M | $7M | $7M | $7M | $14M | $21M | $4M | $3M | $20M | $7M | $5M | $4M | |
| Capital Leases | · | · | $5.0K | $21.0K | $37.0K | $52.0K | $66.0K | · | · | · | $22.0K | $38.0K | $54.0K | · | · | · | |
| Total Liabilities | $205M | $22M | $20M | $18M | $17M | $17M | $18M | $17M | $23M | $21M | $20M | $19M | $20M | $23M | $21M | $19M | |
| Common Stock | $170.0K | $121.0K | $121.0K | $121.0K | $118.0K | $103.0K | $103.0K | $103.0K | $103.0K | $103.0K | $90.0K | $90.0K | $87.0K | $79.0K | $79.0K | $79.0K | |
| Retained Earnings | $-345M | $-270M | $-260M | $-246M | $-231M | $-218M | $-206M | $-193M | $-181M | $-172M | $-160M | $-153M | $-145M | $-125M | $-112M | $-101M | |
| AOCI | $-88.0K | $2.0K | $10.0K | $9.0K | $3.0K | $6.0K | $31.0K | $75.0K | $-7.0K | $4.0K | $4.0K | $4.0K | $4.0K | $4.0K | $4.0K | $4.0K | |
| Stockholders' Equity | $-15M | $11M | $22M | $34M | $42M | $10M | $21M | $31M | $42M | $49M | $4M | $10M | $443.0K | $1M | $13M | $21M | |
| Liabilities + Equity | $190M | $33M | $42M | $52M | $59M | $27M | $39M | $48M | $65M | $70M | $24M | $29M | $21M | $24M | $34M | $41M | |
| Shares Outstanding | 102,717,200 | 53,240,988 | 53,233,988 | 52,812,488 | 49,685,072 | 34,685,072 | 34,685,072 | 34,389,946 | 34,341,303 | 34,251,911 | 21,165,760 | 21,105,760 | 17,930,362 | 9,710,747 | 9,681,855 | 9,473,577 |
Cash Flow
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $58.0K | $57.0K | $57.0K | $54.0K | $55.0K | $62.0K | $58.0K | $57.0K | $57.0K | $57.0K | $58.0K | $55.0K | $58.0K | $55.0K | $56.0K | $60.0K | |
| Stock-based Comp | $7M | $-685.0K | $1M | $2M | $3M | $2M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $829.0K | $840.0K | $823.0K | |
| Amort. of Intangibles | · | $100.0K | $-100.0K | $100.0K | $100.0K | $100.0K | $-100.0K | $100.0K | $100.0K | $100.0K | $100.0K | $100.0K | $100.0K | $100.0K | $100.0K | $100.0K | |
| Operating Cash Flow | $-11M | $-7M | $-18M | $-11M | $-9M | $-11M | $-9M | $-10M | $-5M | $-5M | $-5M | $-7M | $-8M | $-11M | $-8M | $-7M | |
| Investing Cash Flow | $-138M | $14M | $709.0K | $-13M | $7M | $11M | $12M | $13M | · | · | · | · | · | · | · | · | |
| Financing Cash Flow | $168M | $21.0K | $6M | $4M | · | · | $682.0K | $-8M | $-153.0K | $56M | $0 | $15M | $47.0K | $146.0K | $1M | $95.0K | |
| Net Change in Cash | $20M | $7M | $-11M | $-20M | $39M | $263.0K | $3M | $-5M | $-52M | $51M | $-5M | $9M | $-8M | $-11M | $-7M | $-7M |
Profitability
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROA | -60.0% | -33.6% | · | -28.9% | -20.6% | -26.3% | · | -34.6% | -18.1% | -14.3% | -29.6% | -26.2% | -29.3% | -42.5% | -26.3% | -20.4% | |
| ROE | -554.0% | -97.0% | · | -44.4% | -30.3% | -43.0% | · | -70.7% | -32.6% | -26.0% | -279.7% | -72.1% | -82.2% | -73.2% | -38.8% | -29.4% |
Liquidity & Solvency
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.0 | 2.6 | · | 5.1 | 6.6 | 3.5 | · | 6.8 | 4.6 | 3.3 | 5.4 | 7.7 | 0.9 | 3.0 | 5.8 | 9.4 | |
| Quick Ratio | 0.9 | 2.5 | · | 4.9 | 6.5 | 3.3 | · | 6.4 | 4.5 | 3.2 | 4.9 | 7.3 | 0.8 | 2.6 | 5.5 | 9.1 |
Per Share
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $-0.14 | $0.20 | · | $0.64 | $0.84 | $0.30 | · | $0.91 | $1.23 | $1.44 | $0.19 | $0.46 | $0.02 | $0.11 | $1.36 | $2.26 | |
| Cash Flow / Share | · | $-0.13 | · | · | · | $-0.32 | · | · | · | $-0.21 | · | · | $-0.46 | · | · | · | |
| Cash / Share | $0.47 | $0.53 | · | $0.60 | $1.04 | $0.38 | · | $0.28 | $0.43 | $1.94 | $0.94 | $1.19 | $0.92 | $1.87 | $3.03 | $3.84 | |
| EPS (TTM) | $-1.50 | $-1.07 | · | $-1.39 | $-1.47 | $-1.35 | · | $-1.10 | $-1.08 | $-1.26 | $-2.04 | $-3.05 | $-3.70 | $-3.92 | $-3.28 | $-3.73 |
Valuation (TTM)
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income TTM | $-114M | $-52M | · | $-52M | $-50M | $-46M | · | $-33M | $-28M | $-27M | $-36M | $-42M | $-44M | $-38M | $-32M | $-33M | |
| Market Cap | $671M | $157M | · | $166M | $112M | $93M | · | $163M | $161M | $156M | $91M | $110M | $122M | $32M | $47M | $72M | |
| P/E | -4.4 | -2.7 | · | -2.3 | -1.5 | -2.0 | · | -4.3 | -4.4 | -3.6 | -2.1 | -1.7 | -1.8 | -0.8 | -1.5 | -2.0 | |
| P/B | -45.7 | 14.7 | · | 4.9 | 2.7 | 9.0 | · | 5.2 | 3.8 | 3.2 | 22.5 | 11.3 | 275.2 | 30.7 | 3.6 | 3.3 | |
| P / Tangible Book | · | 17.5 | · | 5.2 | 2.8 | 11.1 | · | 5.6 | 4.0 | 3.3 | 51.9 | 14.9 | · | · | 4.5 | 3.8 | |
| P / Cash Flow | · | -22.6 | · | · | · | -8.4 | · | · | · | -29.5 | · | · | -14.7 | · | · | -10.6 | |
| Earnings Yield | -23.0% | -36.4% | · | -44.1% | -65.0% | -50.6% | · | -23.2% | -23.0% | -27.7% | -47.4% | -58.8% | -54.4% | -118.8% | -67.2% | -49.3% |
Most recent period on the left · null values shown as ·
Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Net Income | $-55M | $-40M | $-30M | $-42M | $-33M |
| Diluted EPS | $-1.25 | $-1.24 | $-1.50 | $-4.00 | $-4.08 |
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Current Ratio | · | 5.5 | 0.8 | · | 9.8 |
| Quick Ratio | · | 5.1 | 0.7 | · | 9.5 |
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Free Cash Flow | · | · | $-24M | · | · |
Institutional owners (13F) 123 filers · $548.5M total · As of Sept. 30, 2026
Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.
Holders
123
Value held
$548.5M
New positions
48
Exited positions
17
Institutional activity — Q2 2026 vs prior quarter
| New positions | Exited positions | Increased | Decreased | Net shares change |
|---|---|---|---|---|
| 48 (+29 vs prior Q) | 17 (+8 vs prior Q) | 40 (+20 vs prior Q) | 14 (-9 vs prior Q) | +59.9M |
Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.
| Institution | Value | Shares | % of tracked 13F | Type |
|---|---|---|---|---|
| Frazier Life Sciences Management, L.P. | $49,724,879 | 7,614,836 | 9.06% | Shares |
| TPG GP A, LLC | $44,910,597 | 6,877,580 | 8.19% | Shares |
| venBio Partners LLC | $38,623,122 | 5,914,720 | 7.04% | Shares |
| Logos Global Management LP | $35,425,250 | 5,425,000 | 6.46% | Shares |
| BlackRock, Inc. | $34,426,271 | 5,272,017 | 6.28% | Shares |
| FRANKLIN RESOURCES INC | $32,344,527 | 4,953,220 | 5.90% | Shares |
| Paradigm Biocapital Advisors LP | $32,335,620 | 4,951,856 | 5.89% | Shares |
| VANGUARD CAPITAL MANAGEMENT LLC | $27,039,502 | 4,140,812 | 4.93% | Shares |
| Propel Bio Management, LLC | $26,342,138 | 4,034,018 | 4.80% | Shares |
| MARSHALL WACE, LLP | $24,620,145 | 3,770,313 | 4.49% | Shares |
| STATE STREET CORP | $19,234,285 | 2,945,526 | 3.51% | Shares |
| Venrock Adviser, LLC | $17,964,239 | 2,751,032 | 3.27% | Shares |
| Vivo Capital, LLC | $17,964,239 | 2,751,032 | 3.27% | Shares |
| EVENTIDE ASSET MANAGEMENT, LLC | $14,496,600 | 2,220,000 | 2.64% | Shares |
| GEODE CAPITAL MANAGEMENT, LLC | $13,471,818 | 2,062,721 | 2.46% | Shares |
| Alyeska Investment Group, L.P. | $12,574,965 | 1,925,722 | 2.29% | Shares |
| VANGUARD GROUP INC | $12,297,331 | 2,474,312 | 2.24% | Shares |
| Simplify Asset Management Inc. | $9,351,646 | 1,432,105 | 1.70% | Shares |
| WELLINGTON MANAGEMENT GROUP LLP | $9,317,755 | 1,426,915 | 1.70% | Shares |
| Caption Management, LLC | $7,676,015 | 1,175,500 | 1.40% | Call option |
| LPL Financial LLC | $5,891,725 | 902,255 | 1.07% | Shares |
| NORTHERN TRUST CORP | $4,856,753 | 743,760 | 0.89% | Shares |
| Spruce Street Capital LP | $4,810,240 | 736,637 | 0.88% | Shares |
| VANGUARD FIDUCIARY TRUST CO | $3,877,194 | 593,751 | 0.71% | Shares |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $3,771,075 | 577,500 | 0.69% | Call option |
| RAYMOND JAMES FINANCIAL INC | $3,567,457 | 546,318 | 0.65% | Shares |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $3,510,502 | 537,596 | 0.64% | Shares |
| KVP Capital Advisors, LP | $3,019,178 | 462,355 | 0.55% | Shares |
| TWO SIGMA INVESTMENTS, LP | $2,880,951 | 441,187 | 0.53% | Shares |
| UBS Group AG | $2,043,916 | 313,004 | 0.37% | Shares |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $1,515,861 | 232,138 | 0.28% | Shares |
| Caption Management, LLC | $1,487,096 | 227,733 | 0.27% | Shares |
| SILVERARC CAPITAL MANAGEMENT, LLC | $1,483,472 | 227,178 | 0.27% | Shares |
| Bank of New York Mellon Corp | $1,424,364 | 218,126 | 0.26% | Shares |
| JANE STREET GROUP, LLC | $1,331,467 | 203,900 | 0.24% | Call option |
| CITADEL ADVISORS LLC | $1,326,243 | 203,100 | 0.24% | Call option |
| Nuveen, LLC | $1,248,210 | 191,150 | 0.23% | Shares |
| BANK OF AMERICA CORP /DE/ | $1,208,540 | 185,075 | 0.22% | Shares |
| RENAISSANCE TECHNOLOGIES LLC | $1,162,660 | 178,049 | 0.21% | Shares |
| WELLS FARGO & COMPANY/MN | $1,114,233 | 170,633 | 0.20% | Shares |
| TWO SIGMA ADVISERS, LP | $1,043,203 | 209,900 | 0.19% | Shares |
| CITADEL ADVISORS LLC | $804,032 | 123,129 | 0.15% | Shares |
| CANTOR FITZGERALD, L. P. | $794,250 | 121,631 | 0.14% | Shares |
| BNP PARIBAS FINANCIAL MARKETS | $791,534 | 121,215 | 0.14% | Shares |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $677,161 | 103,700 | 0.12% | Put option |
| Shay Capital LLC | $606,049 | 92,810 | 0.11% | Shares |
| XTX Topco Ltd | $587,896 | 90,030 | 0.11% | Shares |
| RHUMBLINE ADVISERS | $568,253 | 87,023 | 0.10% | Shares |
| Blue Trust, Inc. | $560,849 | 85,888 | 0.10% | Shares |
| Diametric Capital, LP | $530,098 | 81,179 | 0.10% | Shares |
Activists & 5%+ owners 9 positions
Investors who filed SEC Schedule 13D — beneficial ownership above 5% with an intent to influence the issuer (activist stakes, board campaigns, M&A). Each row shows the most recent known state of that filer's position.
| Filer | Filed | Stake | Status | Purpose | Filing |
|---|---|---|---|---|---|
| venBio Global Strategic Fund V, L.P., venBio Global Strategic GP V, LLC | April 27, 2026 | 9.99% | Initial filing | Passive investment | SEC |
| TPG GP A, LLC, James G. Coulter, Jon Winkelried | April 24, 2026 | 12.60% | Initial filing | Board campaign | SEC |
| Dialectic Capital Management, LP, Dialectic Partners, LLC, Dialectic Life Sciences SPV LLC, Dialectic LS Manager LLC, John Fichthorn ×3 filings | March 23, 2023 | · | Initial filing | · | SEC |
| Anthony Clarke | Aug. 11, 2017 | · | Initial filing | Passive investment | SEC |
| Richard Stewart | Aug. 11, 2017 | · | Initial filing | Passive investment | SEC |
| Working Opportunity Fund (EVCC) Ltd., GrowthWorks Capital Ltd. ×5 filings | Feb. 14, 2011 | · | Initial filing | · | SEC |
| Oct. 28, 2010 | · | Initial filing | · | SEC | |
| Abingworth LLP | Aug. 20, 2010 | · | Initial filing | Passive investment | SEC |
| SCHERING BERLIN VENTURE CORPORATION, SCHERING BERLIN INC., SCHERING INTERNATIONAL HOLDING GmbH, SCHERING AKTIENGESELLSCHAFT | Oct. 31, 2005 | · | Initial filing | Passive investment | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Company insiders 48 insiders · 17 officers · 26 directors
| Insider | Role | Last activity | Shares owned | Buys 12m | Sells 12m | Net 12m |
|---|---|---|---|---|---|---|
| Andrew D. Goldberg | CEO and President | April 18, 2026 A | · | 0 | 0 | $0 |
| John Bencich | CEO | Aug. 16, 2024 A | 100,636 | 0 | 0 | $0 |
| Mark K Oki | Chief Financial Officer | Jan. 28, 2026 A | 127,940 | 0 | 0 | $0 |
| Michelle Renee Griffin | CFO | May 8, 2012 A | · | 0 | 0 | $0 |
| Stephen Charles Anderson | CFO and Secretary | Dec. 31, 2009 A | 10,000 | 0 | 0 | $0 |
| Alan Fuhrman | Senior Vice President & CFO | March 18, 2008 A | · | 0 | 0 | $0 |
| Cindy Jacobs | President & CMO | Sept. 4, 2025 M | 115,585 | 0 | 0 | $0 |
| Mark Lawrence Rubinstein | Chief Medical Officer | Jan. 28, 2026 A | · | 0 | 0 | $0 |
| Craig Donnelly | Chief Operations Officer | Jan. 28, 2026 A | · | 0 | 0 | $0 |
| Jaime Xinos | Chief Commercial Officer | Jan. 28, 2026 A | 74,432 | 0 | 0 | $0 |
| Jerry Wann | Principal Accounting Officer | Jan. 28, 2026 A | 32,694 | 0 | 0 | $0 |
| Erik Atkisson | Chief Legal Officer | Dec. 4, 2025 A | · | 0 | 0 | $0 |
| Anthony Clarke | CSO | April 28, 2022 M | 3,502 | 0 | 0 | $0 |
| Susan D. Wyrick | PAO | March 14, 2014 A | 1,312 | 0 | 0 | $0 |
| Cameron William Lawrence | Principal Accounting Officer | May 8, 2012 A | 950 | 0 | 0 | $0 |
| Craig Steven Eudy | Principal Accounting Officer | Dec. 29, 2006 A | · | 0 | 0 | $0 |
| Michael B Stewart | Sr. VP & Chief Medical Officer | Dec. 16, 2005 A | · | 0 | 0 | $0 |
| Richard Alistair Stewart | Director | Aug. 19, 2026 S | 208,249 | 0 | 1 | $-175,115 |
| Reid Alexander Waldman | Director | July 27, 2026 A | · | 0 | 0 | $0 |
| Christopher Nathan Martin | Director | July 27, 2026 A | · | 0 | 0 | $0 |
| Thomas Sellig | Director | July 27, 2026 A | · | 0 | 0 | $0 |
| Nancy R. Phelan | Director | July 27, 2026 A | · | 0 | 0 | $0 |
| Aaron Royston | Director | July 27, 2026 A | · | 0 | 0 | $0 |
| Jeffrey S Farrow | Director | July 27, 2026 A | · | 0 | 0 | $0 |
| Thomas Braxton King | Director | Sept. 4, 2025 M | 315,142 | 0 | 0 | $0 |
| Kristen B. Slaoui | Director | June 6, 2025 A | · | 0 | 0 | $0 |
| Stuart Duty | Director | June 6, 2025 A | · | 0 | 0 | $0 |
| Bridget A Martell | Director | June 6, 2025 A | · | 0 | 0 | $0 |
| Vaughn B Himes | Director | Jan. 22, 2024 A | · | 0 | 0 | $0 |
| Donald Joseph | Director | May 31, 2022 A | · | 0 | 0 | $0 |
| Martin A Mattingly | Director | May 31, 2022 A | 10,500 | 0 | 0 | $0 |
| Jay M Moyes | Director | May 31, 2022 A | · | 0 | 0 | $0 |
| Scott Daniel Cormack | Director | May 12, 2020 A | 14,810 | 0 | 0 | $0 |
| PARKER H STEWART | Director | May 12, 2020 A | 12,500 | 0 | 0 | $0 |
| Neil James Clendeninn | Director | May 26, 2016 A | 22,421 | 0 | 0 | $0 |
| Jack Goldstein | Director | May 26, 2016 A | 17,500 | 0 | 0 | $0 |
| David V Smith | Director | May 26, 2016 A | 9,500 | 0 | 0 | $0 |
| Dwight Winstead | Director | May 17, 2010 M | 0 | 0 | 0 | $0 |
| Patrick Robert Brady | Director | Dec. 22, 2009 M | 21,130 | 0 | 0 | $0 |
| Robert E Ivy | Director | May 18, 2007 M | 1,700 | 0 | 0 | $0 |
| George W Dunbar JR | Director | May 10, 2007 A | 3,250 | 0 | 0 | $0 |
| VENTURES WEST CAPITAL LTD | 10% owner | Dec. 15, 2008 S | 41,763 | 0 | 0 | $0 |
| SAC CAPITAL ADVISORS LLC | 10% owner | Feb. 19, 2004 P | 1,419,752 | 0 | 0 | $0 |
| SAC CAPITAL ASSOCIATES LLC | 10% owner | Feb. 19, 2004 P | 867,376 | 0 | 0 | $0 |
| S A C CAPITAL MANAGEMENT L L C | 10% owner | Feb. 19, 2004 P | 1,419,752 | 0 | 0 | $0 |
| Steven A. Cohen | 10% owner | Feb. 19, 2004 P | 1,419,752 | 0 | 0 | $0 |
| Michael A Martino | · | July 6, 2010 M | 11,000 | 0 | 0 | $0 |
| Richard J Klein | · | Dec. 29, 2003 A | · | 0 | 0 | $0 |
Insiders from SEC Form 3/4/5 filings; net = open-market P/S only
ETF ownership Held by 13 ETFs
Weight reflects direct equity holdings (N-PORT) only; leveraged or derivative-based funds may hold additional swap exposure not shown.
| Fund | Weight | Units | As of | Source |
|---|---|---|---|---|
| BBC · ETFis Series Trust I | 0.78% | 56,308 NS | July 31, 2026 | N-PORT |
| DWAS · Invesco Exchange-Traded Fund Trust … | 0.36% | 196,745 SH | Oct. 2, 2026 | Daily |
| IWC · iShares Trust | 0.13% | 264,043 SH | Sept. 11, 2026 | Daily |
| LABU · Direxion Shares ETF Trust | 0.06% | 45,865 NS | July 31, 2026 | N-PORT |
| IWO · iShares Trust | 0.04% | 731,016 SH | Sept. 11, 2026 | Daily |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0.03% | 83,121 SH | Aug. 19, 2026 | Daily |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0.02% | 447,963 SH | Aug. 19, 2026 | Daily |
| IWM · iShares Trust | 0.02% | 1,986,639 SH | Sept. 11, 2026 | Daily |
| PWS · Pacer Funds Trust | 0.02% | 627 NS | July 31, 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0.01% | 957,103 SH | Aug. 19, 2026 | Daily |
| IWV · iShares Trust | 0.00% | 31,805 SH | Sept. 9, 2026 | Daily |
| VTI · VANGUARD INDEX FUNDS | 0.00% | 3,108,369 SH | Aug. 19, 2026 | Daily |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0.00% | 6,512 SH | Aug. 19, 2026 | Daily |
ACHV Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside
rating · 17 analysts
BUY
Median target
$13.00
+79.6%
3 17.6%
Strong Buy
13 76.5%
Buy
1 5.9%
Hold
0 0.0%
Sell
0 0.0%
Strong Sell
12-Month Price Target
13 analysts · 2026-10-04Mean target $14.15 +95.5%
← Below all targets
Current price $7.24
Low$9.00
Mean$14.15
High$21.00
Peer comparison (GICS sub-industry) Key metrics vs sector peers
FY basis, prices as of each company's last fiscal year-end close.
| Ticker | Market Cap | P/E | Rev YoY | Net Margin | ROE | Gross Margin |
|---|---|---|---|---|---|---|
| ACHV | · | -4.0 | · | · | · | · |
| ANNX | $750M | -3.7 | · | · | -100.7% | · |
| AVTX | $336M | -3.1 | -86.6% | -132642.4% | -83.4% | · |
| DSGN | $567M | -7.7 | · | · | -32.8% | · |
| GERN | $845M | -10.2 | -60.2% | · | -34.4% | · |
| CADL | $310M | -7.8 | · | · | -53.7% | · |
| FDMT | $432M | -3.1 | 230194.6% | -164.4% | -30.2% | · |
| GYRE | $645M | 353.0 | 10.2% | 8.5% | 11.7% | · |
| SLDB | $445M | -2.8 | · | · | -79.5% | · |
| VSTM | $600M | -2.6 | 209.1% | -677.6% | -449.2% | · |
| IMMX | $277M | -5.9 | · | · | -59.8% | · |
My Metrics Your personal watchlist — selected rows from Full Fundamentals
Pick the metrics that matter to you — click the + next to any row in Full Fundamentals above.
Your selection is saved and follows you across all tickers.
Source: SEC 10-Q filed Aug 11, 2026